Skip to content
New Commercial Leadership: Kirk Stockwood Joins Octave –
Read More
For Providers
The MSDA Test Overview
Get Connected
For Patients
The MSDA Test
Billing Resources
Where Can I Get The Test?
Clinical Evidence
All Publications
Clinical Utility Study
News & Events
AAN 2026
ACTRIMS 2026
Media & Blog
For Providers
The MSDA Test Overview
Get Connected
For Patients
The MSDA Test
Billing Resources
Where Can I Get The Test?
Clinical Evidence
All Publications
Clinical Utility Study
News & Events
AAN 2026
ACTRIMS 2026
Media & Blog
Contact Us
Get In Touch
For Providers
The MSDA Test Overview
Get Connected
For Patients
The MSDA Test
Billing Resources
Where Can I Get The Test?
Clinical Evidence
All Publications
Clinical Utility Study
News & Events
AAN 2026
ACTRIMS 2026
Media & Blog
For Providers
The MSDA Test Overview
Get Connected
For Patients
The MSDA Test
Billing Resources
Where Can I Get The Test?
Clinical Evidence
All Publications
Clinical Utility Study
News & Events
AAN 2026
ACTRIMS 2026
Media & Blog
Get In Touch
For Providers
The MSDA Test Overview
Get Connected
For Patients
The MSDA Test
Billing Resources
Where Can I Get The Test?
Clinical Evidence
All Publications
Clinical Utility Study
News & Events
AAN 2026
ACTRIMS 2026
Media & Blog
For Providers
The MSDA Test Overview
Get Connected
For Patients
The MSDA Test
Billing Resources
Where Can I Get The Test?
Clinical Evidence
All Publications
Clinical Utility Study
News & Events
AAN 2026
ACTRIMS 2026
Media & Blog
Clinical Validation Study Results for a Multivariate Proteomic MS Disease Activity Test
March 16, 2022
in
By
Ryan Delduca
Comment
No Comments
Click here
